Home » Drug Delivery » Inhaled Drug Delivery » Dry Powder Inhalers Market Report

Dry Powder Inhalers Market Report


dry powder inhalers market report  Dry Powder Inhalers Market Report • Published April 2017  •  Catalog no. DPJ444K17  •  Price US $3,850


Converging Factors Driving the Growth of Dry Powder Inhaled Delivery

The Dry Powder Inhalers Market Report examines the rising potential of dry powder inhalation. This market is being driven by research activity in powder formulations, advances in particle engineering, and the development of novel device architectures. The combination of improved particle properties and more efficient inhaler designs is creating new opportunities for dry powder inhalation and expanding the range of active compounds that can be effectively delivered to the lung via DPI. As aging population demographics and managed care initiatives drive growth in home health care and self-administration of drug therapies, inhaled medicine is increasingly being viewed as patient – friendly and cost -effective. Our analysis contained in the dry powder inhalers market report illustrates that inhaled administration in general, and DPI in particular, are well positioned to take advantage of these trends and evolve into a significant factor in the future of pharmaceutical development and the commercialization of therapeutic drugs.

Bar_Graph  Dry Powder Inhalers Report – Brochure(Download PDF)

Blue document  Dry Powder Inhalers Report Order Form (Download PDF)


Dry Powder Inhalers – What You Will Learn

 What inhalable drugs are supplied in powder form, how are they marketed, what are the device specifics, and who markets them?
 What inhalable dry powder drugs are in late stage development, who are the developers, and what indications are they targeting?
 What are the major factors driving inhaled dry powder drug/device demand?
 What is the size of the market today, who are the market share leaders, and what will the market share be in 2024?
 How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
 What are the essential design factors, technologies and market development issues for dry powder inhalation products?
 What are the significant economic, technology, and regulatory factors affecting the market for dry powder inhalers?


 


Dry Powder Inhalers Market Report – Summary of Contents

Executive Summary

Inhaled Drug Therapeutics

Devices and Formulations
Market Segments and Indications
Competing Technologies
Established Therapeutic Targets
Demographics and Growth
Market Drivers
Risk Factors

Dry Powder Technology & Markets

Dry Powder Formulations
Particle Technology/Engineering
Dry Powder Processing
Dry Powder Packaging
DPI Product Segments
DPI Inhaler Design Categories
Reservoir Devices
Discrete Dose Devices
Proprietary Technology Devices
DPI Device Availability
Customer-specific DPI Devices
Multi-client DPI Devices
Development-stage Devices

DPI Product Assessment & Analysis

FDA Approved DPI Products

Mono-drug Products
Aclidinium
Albuterol
Budesonide
Fluticasone
Formoterol
Glycopyrronium
Indacaterol
Insulin
Loxapine
Mometasone
Salmeterol
Tiotropium
Tobramycin
Umeclidinium
Zanamivir

Dual Drug Products
Fluticasone+Salmeterol
Fluticasone+Vilanterol
Glycopyrronium+Indacaterol
Umeclidium+Vilanterol

EMA Approved DPI Products

Mono-drug Products
Aclidinium
Glycopyrronium
Indacaterol
Umeclidinium

Dual Drug Products
Aclidinium+Formoterol
Budesonide+Formoterol
Fluticasone+Salmeterol
Fluticasone+Vilanterol
Glycopyrronium+Indacaterol
Umeclidinium+Vianterol

Therapeutic Segment Analysis, Data & Forecasts

Upper Respiratory
Asthma
COPD
Bronchospasm
Systemic Indications
Hereditary Disease
Infectious Diseases
Metabolic Conditions
Neurology
Other Systemic Markets

Market Factors

Regulatory Issues
Device Branding
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles


Useful Links

Dry Powder Inhaler Technology